Skip to content
buyModerate cluster of 4

Declan Doogan bought $102k of TENX

director at TENAX THERAPEUTICS, INC.. 53,000 shares at an average of $1.92, traded Sep 16, 2026, filed Sep 17, 2026.

Conviction score
50
Value
$102k
53,000 shares
Holdings after
55,274
+2331% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $102k at market
    +10
  • Relative to holdings
    Holdings up 2331%
    +10
  • Price context
    No price history yet
    0
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

TENXOct 9, 2026 · close 1.87
Since filing Sep 17, 2026: +0.5%SPY +2.3% · excess -1.8%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001193125-26-394831, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 16, 2026POpen-market purchase
Common Stock
+53,000$1.92$102k55,27426 d ago

Related signals

Other insiders at TENAX THERAPEUTICS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
50Moderate
TENXbuy 4
TENAX THERAPEUTICS, INC.
Christopher Thomas Giordano
CEO
$20k
10,850 shares
+96%
47Moderate
TENXbuy 4
TENAX THERAPEUTICS, INC.
Thomas R Staab II
Chief Financial Officer
$11k
5,675 shares
+57%
55Moderate
TENXbuy 4
TENAX THERAPEUTICS, INC.
ADAR1 Capital Management, LLC
owner
$1.6M
900,000 shares
+16%
50Moderate
TENXbuy 3
TENAX THERAPEUTICS, INC.
ADAR1 Capital Management, LLC
owner
$1.4M
770,333 shares
+16%
37Weak
TENXbuy
TENAX THERAPEUTICS, INC.
Stuart Rich
Chief Medical Officer
$51k
5,000 shares
+200%
39Weak
TENXbuy 2
TENAX THERAPEUTICS, INC.
Stuart Rich
Chief Medical Officer
$46k
5,000 shares
+1880%
48Moderate
TENXbuy 4
TENAX THERAPEUTICS, INC.
Christopher Thomas Giordano
CEO
$20k
2,605 shares
-
38Weak
TENXbuy 3
TENAX THERAPEUTICS, INC.
June Sherie Almenoff
director
$15k
1,993 shares
-
38Weak
TENXbuy 3
TENAX THERAPEUTICS, INC.
June Sherie Almenoff
director
$15k
1,993 shares
-
52Moderate
TENXbuy 3
TENAX THERAPEUTICS, INC.
Thomas McGauley
Interim CFO
$58k
8,000 shares
-

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.